-+ 0.00%
-+ 0.00%
-+ 0.00%

CARSGEN ANNOUNCES DATA OF ALLOGENEIC BCMA CAR-T CELL THERAPY CT0596 FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA AT THE 2025 ASH ANNUAL MEETING

Reuters·12/08/2025 00:15:02

Please log in to view news